As of Jun 29
| +0.19 / +0.99%|
The 12 analysts offering 12-month price forecasts for Depomed Inc have a median target of 24.00, with a high estimate of 28.00 and a low estimate of 20.00. The median estimate represents a +23.58% increase from the last price of 19.42.
The current consensus among 12 polled investment analysts is to Buy stock in Depomed Inc. This rating has held steady since June, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.